EN
HI
Aspira Pathlab & Diagnostics Chart
Aspira Pathlab & Diagnostics Share Key Metrics
Volume
16937.00
Market Cap
133.20 CR
LTQ@LTP
8@135.88
ATP
128.26
Var Margin
100 %
Circuit Range
122.94-135.88
Delivery %
100 %
Value
21.72 L
ASM/GSM
No
Market Lot
1
Summary
Aspira Pathlab & Diagnostics share price is ₹135.88 as of 29 May, 2026. The stock Aspira Pathlab & Diagnostics intraday movement has stayed between ₹122.94 and ₹135.88, while on a 52-week basis,Aspira Pathlab & Diagnostics price 52 week high is ₹135.88 & its 52 week low is ₹49.00.
In terms of trading activity, Aspira Pathlab & Diagnostics has recorded a volume of 16937 shares, The Aspira Pathlab & Diagnostics has a market cap of ₹10293000 CR. The stock’s Average Traded Price (ATP) stands at ₹128.26, while the Last Traded Quantity at Last Traded Price (LTQ@LTP) is 8 @ ₹135.88.
Aspira Pathlab & Diagnostics operates within a circuit range of ₹122.94 – ₹135.88, with a Value of ₹21.72 L. The Delivery Percentage for the day is 100%. Additionally, Aspira Pathlab & Diagnostics currently falls under the No framework, and trades with a market lot size of 1.
Aspira Pathlab & Diagnostics Fundamentals
View MoreP/E Ratio
55.52
P/B Ratio
10.54
Div. Yield
0
Sector P/E
48.24
Sector P/B
-15.77
Sec. Div. Yield
0.19
Aspira Pathlab & Diagnostics Resistance and Support
Pivot 128.25
Resistance
First Resistance
131.62
Second Resistance
133.84
Third Resistance
137.21
Support
First Support
126.03
Second Support
122.66
Third Support
120.44
Aspira Pathlab & Diagnostics Corporate Actions
| Date | Agenda |
|---|---|
| 2026-05-23 | Audited Results |
| 2026-02-10 | Quarterly Results |
| 2025-11-12 | Quarterly Results |
| 2025-08-12 | Quarterly Results |
| 2025-05-16 | Audited Results |
| 2025-02-07 | Quarterly Results |
Aspira Pathlab & Diagnostics News
Aspira Pathlab & Diagnostics Ltd - 540788 - Announcement under Regulation 30 (LODR)-Change in Management Control
Aspira Pathlab appointed Mr. Vaibhav Odhekar as an Additional Executive Director for five years, effective May 23, 2026. He is a seasoned entrepreneur with over two decades of experience in technology-led platform businesses.
May 23 2026 19:47:06
Aspira Pathlab & Diagnostics Ltd - 540788 - Appointment Of M/S. Vishal J Bhanushali & Associates, Practicing Chartered Accountant (Firm Registration Number: 145806W), Having Membership No. 179979, As An Internal Auditor Of The Company For The Financial Year 2026-2027.
Aspira Pathlab has appointed Vaibhav Odhekar as an Additional Executive Director for a five-year term, subject to shareholder approval. The company also appointed Mrs. Neetu Maurya as Company Secretary and Compliance Officer, and M/s. Vishal J Bhanushali & Associates as Internal Auditor for FY 2026-27.
May 23 2026 19:44:28
Read More
Aspira Pathlab & Diagnostics Management
| Name | Position |
|---|---|
| Haseeb A Drabu | Chairman |
| Pankaj Shah | Managing Director & Chief Executive Officer |
Aspira Pathlab & Diagnostics Similar Stocks
Samrat Pharmachem Ltd.
248.90
23.00 (10.18%)
Alpa Laboratories Ltd.
70.96
0.51 (0.72%)
Lotus Eye Hospital And Institute Ltd.
108.05
-1.15 (1.05%)
Source Natural Foods and Herbal Supplements Ltd.
110.00
-2.00 (1.79%)
Lasa Supergenerics Ltd.
8.30
0.18 (2.22%)
Star Imaging and Path Lab Ltd.
69.99
-2.61 (3.60%)
Raaj Medisafe India Ltd.
88.01
-1.00 (1.12%)
Aspira Pathlab & Diagnostics FAQs
The Buying Price of Aspira Pathlab & Diagnostics share is 135.88 For live prices and instant trading, you can log in to your Choice trading account or open a Free Demat account with Choice.
To buy Aspira Pathlab & Diagnostics stocks, log in to your Choice trading account. If you don’t have one, open a Choice Demat account. Then, add funds, search for Aspira Pathlab & Diagnostics, choose your preferred order type, and place the trade.
The Price-to-earnings (P/E) ratio of Aspira Pathlab & Diagnostics shares is 55.52. You can compare it with the sector average for relative valuation.
The Price to Book (P/B) ratio Aspira Pathlab & Diagnostics shares is 10.54. Useful to assess the stock's value relative to its book value.
To assess Aspira Pathlab & Diagnostics’s valuation compare Sector P/E, P/B which are 48.24 & -15.77 with sector averages, along with growth rates and financial metrics.
The Market Cap of Aspira Pathlab & Diagnostics is 133.20 CR. It indicates the company's size category and trading liquidity.
The 52 week high and low prices of Aspira Pathlab & Diagnostics share price is 135.88 & 49.00. They indicate price extremes, trading ranges, volatility measures, potential support/resistance, and price momentum.
Aspira Pathlab & Diagnostics belongs to the Healthcare sector.
